Therapy News and Research

RSS

Recommendations to address challenges associated with chronic inflammatory diseases

A dramatic increase in the incidence of chronic inflammatory diseases such as asthma, allergy, and irritable bowel syndrome, has led to concern about how modern lifestyles may trigger physiological defense mechanisms.

8 Dec 2011

Study raises questions about breast cancer therapy

The study, which looked at Medicare records of more than 130,000 women, found that those who underwent the faster treatment, called brachytherapy, were about twice as likely to have a mastectomy in the following five years -

8 Dec 2011

Zoledronic acid increases bone mineral density, reduces recurrence in postmenopausal breast cancer

The addition of zoledronic acid to adjuvant endocrine therapy increased bone mineral density and reduced the risk for disease recurrence among postmenopausal women with early hormone receptor-positive breast cancer, according to new data from the ZO-FAST trial.

8 Dec 2011

Ixabepilone-sunitinib combination holds potential against chemotherapy-resistant ovarian cancer

The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.

8 Dec 2011

Viewpoints: Insurance safety net; Orszag on shift in health plans

In this country, three subjects that are guaranteed to generate a heated debate are religion, politics and, you guessed it, health insurance. Of the first two, Mark Twain observed that "people's beliefs and convictions are in almost every case gotten at second-hand."

8 Dec 2011

New gene editing technique can heal sickle cell patients with their own cells

Researchers at the Salk Institute for Biological Studies have developed a way to use patients' own cells to potentially cure sickle cell disease and many other disorders caused by mutations in a gene that helps produce blood hemoglobin.

8 Dec 2011

Combination of two anti-estrogen drugs extends survival time of women with breast cancer

Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.

8 Dec 2011

Adjuvant zoledronic acid shows promise against ER-positive premenopausal breast cancer

Researchers have proven the continuing effectiveness of treating patients with estrogen receptor-positive premenopausal breast cancer with adjuvant zoledronic acid in addition to adjuvant endocrine treatment including ovarian function suppression.

8 Dec 2011

BCX4945 proves effective at clearing malaria infections

An antimalarial agent developed by researchers at Albert Einstein College of Medicine of Yeshiva University proved effective at clearing infections caused by the malaria parasite most lethal to humans - by literally starving the parasites to death. The novel research, carried out on a small number of non-human primates, could bolster efforts to develop more potent therapies against one of the world's leading killers.

8 Dec 2011

Notch inhibitor appears to treat breast cancer

In a novel therapeutic approach to treating breast cancer, Loyola University Medical Center researchers are reporting positive results from a clinical trial of a drug that targets tumor stem cells.

8 Dec 2011

New ways to treat overeating in children and adults

Overeating, whether in children or adults, often takes place even in the absence of hunger, resulting in weight gain and obesity. Current methods to treat such overeating in youth focus on therapies that restrict what kids may eat, requiring them to track their food intake and engage in intensive exercise.

8 Dec 2011

State roundup: Aetna suing over Mich. BCBS hospital deals; ACLU threatens Ohio abortion suit

The latest challenge was a lawsuit filed Tuesday in Detroit's federal court by insurance giant Aetna, one of the nation's largest health plans, with 35 million members. The suit alleges a violation of federal antitrust laws, claiming the Blues raised rates for Michigan consumers over the last four years and used the money to reward hospitals with higher payments if they charged Blues' competitors the same or higher rates.

8 Dec 2011

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Updated results of a Phase III study of Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, show everolimus provided additional time women with advanced breast cancer lived without their disease progressing.

8 Dec 2011

AmLactin can help the skin through menopause

Womanhood definitely has its advantages—studies even show we live longer than men—but menopause isn't on the list of perks. Sometime between the ages of 40-58, our bodies will inevitably experience a drop in estrogen production and begin a metamorphosis.

7 Dec 2011

First Edition: December 7, 2011

In the news today, a status check on the work -- including the Medicare doc fix -- that Congress still needs to attend to before leaving Washington for the holidays.

7 Dec 2011

Majority of women do not receive guideline-recommended breast cancer adjuvant therapy

A first-of-its kind study led by Xiao-Cheng Wu, MD, MPH, Associate Professor of Public Health at LSU Health Sciences Center New Orleans, reports that a significant number of women are not receiving guideline-recommended treatment for breast cancer and what factors contribute.

7 Dec 2011

Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumor-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California.

7 Dec 2011

Headache affects one of every two HIV/AIDS patients

A University of Mississippi study of headaches among HIV patients is being hailed as a critical step to improving treatment and reducing unnecessary medical costs among sufferers.

7 Dec 2011

AFECTAIR may be an effective alternative to SoC for delivery of inhaled nitric oxide

Discovery Laboratories, Inc. today released new data showing that use of AFECTAIR resulted in as much as a 70 percent reduction in the amount of nitric oxide required to deliver the desired dose of the therapeutic gas when compared with current standard of care.

7 Dec 2011

New approach can benefit parents with gender nonconforming and transgender children

How should parents respond when their four years old son insists on wearing girls' clothes, or their daughter switches to using a male version of their name? These are the questions increasingly being asked of family therapist Jean Malpas who writes in Family Process about a new approach to support parents with gender nonconforming and transgender children.

7 Dec 2011

Therapy News and Research

Recommendations to address challenges associated with chronic inflammatory diseases

Study raises questions about breast cancer therapy

Zoledronic acid increases bone mineral density, reduces recurrence in postmenopausal breast cancer

Ixabepilone-sunitinib combination holds potential against chemotherapy-resistant ovarian cancer

Viewpoints: Insurance safety net; Orszag on shift in health plans

New gene editing technique can heal sickle cell patients with their own cells

Combination of two anti-estrogen drugs extends survival time of women with breast cancer

Adjuvant zoledronic acid shows promise against ER-positive premenopausal breast cancer

BCX4945 proves effective at clearing malaria infections

Notch inhibitor appears to treat breast cancer

New ways to treat overeating in children and adults

State roundup: Aetna suing over Mich. BCBS hospital deals; ACLU threatens Ohio abortion suit

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

AmLactin can help the skin through menopause

First Edition: December 7, 2011

Majority of women do not receive guideline-recommended breast cancer adjuvant therapy

Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center

Headache affects one of every two HIV/AIDS patients

AFECTAIR may be an effective alternative to SoC for delivery of inhaled nitric oxide

New approach can benefit parents with gender nonconforming and transgender children

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News